Becoming Children With Perinatal Anoxo-Ischemic Encephalopathy Without Indication of Therapeutic Hypothermia
NCT ID: NCT03744481
Last Updated: 2019-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
68 participants
OBSERVATIONAL
2019-05-19
2019-08-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There are few studies on the becoming of children with a mild anoxic-ischemic encephalopathy and not set hypothermia.
The main hypothesis of the study is that term newborns with anoxo-ischemic encephalopathy who did not require therapeutic hypothermia have normal psychomotor development at 2 years.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
NCT02800018
Neonates with Hypoxic Ischemic Encephalopathy (HIE)
NCT06694545
Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)
NCT05581927
Cooling in Mild Encephalopathy
NCT05889507
Neonatal Hypoxic Ischemic Encephalopathy:Early Diagnosis and Management of Comorbidities
NCT03550612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionaire
Evaluation of psychomotor development in children with mild EAI without indication of therapeutic hypothermia.
Precise analysis of the type (motor, sensory, language, epilepsy) and the severity of sequelae by sending a questionnaire to parents.
Investigation of early, clinical and paraclinical prognostic factors of good or bad neurodevelopmental outcome.
Evaluation of the height-weight growth and the cranial perimeter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the 1st of January 2012 and the 31st of December 2016
* Hospitalized in the neonatal resuscitation department of Croix Rousse in Lyon
* Perinatal asphyxia with clinical signs of encephalopathy
* Indication of therapeutic hypothermia not retained because EAI mild
* Where parents were informed and did not object to participation in the study
Exclusion Criteria
* Stroke
* Children transferred for other criteria (respiratory distress, heart failure ...)
2 Years
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Réanimation néonatale - Hôpital de la Croix Rousse
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL18_0627
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.